IPO WATCH- Is Rameda Pharma the mysterious pharma company planning a USD 61mn IPO? Remember that unnamed pharma company that Financial Regulatory Authority official Sayed Abdel Fadeel said is planning a USD 61 mn initial public offering on the EGX this year? Well, Al Mal is speculating that the company in question is actually Rameda Pharma. Rameda had been looking to list sometime in 2018, but had suspended plans to list — along with Giza Spinning and Weaving and Hassan Allam Holdings — over the emerging markets zombie apocalypse.
More from Enterprise
How correspondent banking works, and what the FinCEN clampdown on Banque Misr UAE means for business
As FinCEN proposes cutting Banque Misr’s UAE branches from USD…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
FRA and EGX eye law change to let LLCs and partnerships set up investment funds
Regulators want to keep Egyptian money from setting up funds…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…